Alcohol modulates expression of DNA methyltranferases and methyl CpG-/CpG domain-binding proteins in murine embryonic fibroblasts

Reproductive Toxicology

Volumn 37, Issue , 2013, Pages 40-48

  Mukhopadhyay, Partha ^a   Rezzoug, Francine ^a   Kaikaus, Jahanzeb ^a   Greene, Robert M ^a   Pisano, M Michele ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Alcohol; DNA methylation; Embryo; Epigenetic; Fetal alcohol syndrome; Fibroblast; Mouse; Proteasome

Indexed keywords

5 METHYLCYTOSINE; ALCOHOL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; FIBROBLAST; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DEGRADATION;

ANIMALS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; ETHANOL; FIBROBLASTS; MICE; NIH 3T3 CELLS;

EID: 84874522953     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.01.003     Document Type: Article

References (76)

1. May P.A., Gossage J.P. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Research & Health 2001, 25:159-167.
2. Kuehn D., Aros S., Cassorla F., Avaria M., Unanue N., Henriquez C., et al. A prospective cohort study of the prevalence of growth, facial, and central nervous system abnormalities in children with heavy prenatal alcohol exposure. Alcoholism, Clinical and Experimental Research 2012, 36:1811-1819.
3. Lipinski R.J., Hammond P., O'Leary-Moore S.K., Ament J.J., Pecevich S.J., Jiang Y., et al. Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependent. PLoS ONE 2012, 7:e43067.
4. Sampson P.D., Streissguth A.P., Bookstein F.L., Little R.E., Clarren S.K., Dehaene P., et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 1997, 56:317-326.
5. Lemoine P., Harrousseau H., Borteyru J., Menuet J. Les enfants de parents alcooliques: Anomalies observées à propos de 127 cas. Quest Medical 1968, 25:476-482.
6. Jones K.L., Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973, 302:999-1001.
7. Jones K.L., Smith D.W., Ulleland C.N., Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973, 1:1267-1271.
8. Floyd R.L., O'Connor M.J., Sokol R.J., Bertrand J., Cordero J.F. Recognition and prevention of fetal alcohol syndrome. Obstetrics and Gynecology 2005, 106:1059-1064.
9. Klingenberg C.P., Wetherill L., Rogers J., Moore E., Ward R., Autti-Ramo I., et al. Prenatal alcohol exposure alters the patterns of facial asymmetry. Alcohol 2010, 44:649-657.
10. Haycock P.C. Fetal alcohol spectrum disorders: the epigenetic perspective. Biology of Reproduction 2009, 81:607-617.
11. Moonat S., Starkman B.G., Sakharkar A., Pandey S.C. Neuroscience of alcoholism: molecular and cellular mechanisms. Cellular and Molecular Life Sciences 2010, 67:73-88.
12. Pandey S.C., Ugale R., Zhang H., Tang L., Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. Journal of Neuroscience 2008, 28:3729-3737.
13. Shukla S.D., Velazquez J., French S.W., Lu S.C., Ticku M.K., Zakhari S. Emerging role of epigenetics in the actions of alcohol. Alcoholism, Clinical and Experimental Research 2008, 32:1525-1534.
14. Kiefer J.C. Epigenetics in development. Developmental Dynamics 2007, 236:1144-1156.
15. MacDonald J.L., Roskams A.J. Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation. Progress in Neurobiology 2009, 88:170-183.
16. Meshorer E. Chromatin in embryonic stem cell neuronal differentiation. Histology and Histopathology 2007, 22:311-319.
17. Mohammad H.P., Baylin S.B. Linking cell signaling and the epigenetic machinery. Nature Biotechnology 2010, 28:1033-1038.
18. Lalande M., Calciano M.A. Molecular epigenetics of Angelman syndrome. Cellular and Molecular Life Sciences 2007, 64:947-960.
19. Shahbazian M.D., Zoghbi H.Y. Rett syndrome and MeCP2: linking epigenetics and neuronal function. American Journal of Human Genetics 2002, 71:1259-1272.
20. Ueda Y., Okano M., Williams C., Chen T., Georgopoulos K., Li E. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 2006, 133:1183-1192.
21. Kaminen-Ahola N., Ahola A., Maga M., Mallitt K.A., Fahey P., Cox T.C., et al. Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genetics 2010, 6:e1000811.
22. Miranda R.C., Pietrzykowski A.Z., Tang Y., Sathyan P., Mayfield D., Keshavarzian A., et al. MicroRNAs: master regulators of ethanol abuse and toxicity. Alcoholism, Clinical and Experimental Research 2010, 34:575-587.
23. Oberlander T.F., Weinberg J., Papsdorf M., Grunau R., Misri S., Devlin A.M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3:97-106.
24. Ouko L.A., Shantikumar K., Knezovich J., Haycock P., Schnugh D.J., Ramsay M. Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders. Alcoholism, Clinical and Experimental Research 2009, 33:1615-1627.
25. Qiang M., Denny A., Chen J., Ticku M.K., Yan B., Henderson G. The site specific demethylation in the 5'-regulatory area of NMDA receptor 2B subunit gene associated with CIE-induced up-regulation of transcription. PLoS ONE 2010, 5:e8798.
26. Garro A.J., McBeth D.L., Lima V., Lieber C.S. Ethanol consumption inhibits fetal DNA methylation in mice: implications for the fetal alcohol syndrome. Alcoholism, Clinical and Experimental Research 1991, 15:395-398.
27. Bonsch D., Lenz B., Fiszer R., Frieling H., Kornhuber J., Bleich S. Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. Journal of Neural Transmission 2006, 113:1299-1304.
28. Feng J., Fouse S., Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatric Research 2007, 61:58R-63R.
29. Liu Y., Balaraman Y., Wang G., Nephew K.P., Zhou F.C. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 2009, 4:500-511.
30. Hermann A., Goyal R., Jeltsch A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. Journal of Biological Chemistry 2004, 279:48350-48359.
31. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
32. Smith S.S., Kaplan B.E., Sowers L.C., Newman E.M. Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:4744-4748.
33. Howell C.Y., Bestor T.H., Ding F., Latham K.E., Mertineit C., Trasler J.M., et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 2001, 104:829-838.
34. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
35. Kaneda M., Okano M., Hata K., Sado T., Tsujimoto N., Li E., et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004, 429:900-903.
36. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M., et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:14412-14417.
37. Martins-Taylor K., Schroeder D.I., LaSalle J.M., Lalande M., Xu R.H. Role of DNMT3B in the regulation of early neural and neural crest specifiers. Epigenetics 2012, 7:71-82.
38. Bogdanovic O., Veenstra G.J. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009, 118:549-565.
39. Defossez P.A., Stancheva I. Biological functions of methyl-CpG-binding proteins. Progress in Molecular Biology and Translational Science 2011, 101:377-398.
40. Ruddock-D'Cruz N.T., Xue J., Wilson K.J., Heffernan C., Prashadkumar S., Cooney M.A., et al. Dynamic changes in the localization of five members of the methyl binding domain (MBD) gene family during murine and bovine preimplantation embryo development. Molecular Reproduction and Development 2008, 75:48-59.
41. Amir R.E., Van Den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999, 23:185-188.
42. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics 2001, 27:322-326.
43. Kaji K., Nichols J., Hendrich B. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development 2007, 134:1123-1132.
44. Greene R.M., Pisano M.M. Palate morphogenesis: current understanding and future directions. Birth Defects Research C. Embryo Today 2010, 90:133-154.
45. Lodish H., Berk A., Kaiser C.A., Krieger M., Bretscher A., Ploegh H., et al. Culturing, visualizing and perturbing cell. Molecular cell biology 2012, W.H. Freeman and Co., New York. 7th ed.
46. Mukhopadhyay P., Webb C.L., Warner D.R., Greene R.M., Pisano M.M. BMP signaling dynamics in embryonic orofacial tissue. Journal of Cellular Physiology 2008, 216:771-779.
47. Sasse J., Gallagher S.R. Staining proteins in gels. Current Protocols in Molecular Biology 2009, 10.6.1-10.6.27. [Chapter 10].
48. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with Image J. Biophotons International 2004, 11:36-42.
49. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Research 1996, 6:995-1001.
50. Boyles A.L., Billups A.V., Deak K.L., Siegel D.G., Mehltretter L., Slifer S.H., et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environmental Health Perspectives 2006, 114:1547-1552.
51. Knudsen T.B., Kleinstreuer N.C. Disruption of embryonic vascular development in predictive toxicology. Birth Defects Research C. Embryo Today 2011, 93:312-323.
52. Obican S.G., Finnell R.H., Mills J.L., Shaw G.M., Scialli A.R. Folic acid in early pregnancy: a public health success story. FASEB Journal 2010, 24:4167-4174.
53. Suarez L., Ramadhani T., Felkner M., Canfield M.A., Brender J.D., Romitti P.A., et al. Maternal smoking, passive tobacco smoke, and neural tube defects. Birth Defects Research. Part A: Clinical and Molecular Teratology 2011, 91:29-33.
54. Kakutani T., Jeddeloh J.A., Flowers S.K., Munakata K., Richards E.J. Developmental abnormalities and epimutations associated with DNA hypomethylation mutations. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:12406-12411.
55. Martin C.C., Laforest L., Akimenko M.A., Ekker M. A role for DNA methylation in gastrulation and somite patterning. Developmental Biology 1999, 206:189-205.
56. Matsuda M., Yasutomi M. Inhibition of cephalic neural tube closure by 5-azacytidine in neurulating rat embryos in vitro. Anatomy and Embryology (Berlin) 1992, 185:217-223.
57. Zhou F.C., Balaraman Y., Teng M., Liu Y., Singh R.P., Nephew K.P. Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcoholism, Clinical and Experimental Research 2011, 35:735-746.
58. Zhou F.C., Chen Y., Love A. Cellular DNA methylation program during neurulation and its alteration by alcohol exposure. Birth Defects Research. Part A: Clinical and Molecular Teratology 2011, 91:703-715.
59. Geiman T.M., Muegge K. DNA methylation in early development. Molecular Reproduction and Development 2010, 77:105-113.
60. Hicks S.D., Middleton F.A., Miller M.W. Ethanol-induced methylation of cell cycle genes in neural stem cells. Journal of Neurochemistry 2010, 114:1767-1780.
61. Bielawski D.M., Zaher F.M., Svinarich D.M., Abel E.L. Paternal alcohol exposure affects sperm cytosine methyltransferase messenger RNA levels. Alcoholism, Clinical and Experimental Research 2002, 26:347-351.
62. Da Lee R., Rhee G.S., An S.M., Kim S.S., Kwack S.J., Seok J.H., et al. Differential gene profiles in developing embryo and fetus after in utero exposure to ethanol. Journal of Toxicology and Environmental Health. Part A 2004, 67:2073-2084.
63. Green M.L., Singh A.V., Zhang Y., Nemeth K.A., Sulik K.K., Knudsen T.B. Reprogramming of genetic networks during initiation of the fetal alcohol syndrome. Developmental Dynamics 2007, 236:613-631.
64. Grenett H.E., Aikens M.L., Tabengwa E.M., Davis G.C., Booyse F.M. Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells. Thrombosis Research 2000, 97:247-255.
65. Higashiyama D., Saitsu H., Komada M., Takigawa T., Ishibashi M., Shiota K. Sequential developmental changes in holoprosencephalic mouse embryos exposed to ethanol during the gastrulation period. Birth Defects Research. Part A: Clinical and Molecular Teratology 2007, 79:513-523.
66. Kumari M., Ticku M.K. Ethanol and regulation of the NMDA receptor subunits in fetal cortical neurons. Journal of Neurochemistry 1998, 70:1467-1473.
67. Miller M.W., Jacobs J.S., Neg Yokoyama R. a nerve growth factor-stimulated gene expressed by fetal neocortical neurons that is downregulated by ethanol. Journal of Comparative Neurology 2003, 460:212-222.
68. Varodayan F.P., Pignataro L., Harrison N.L. Alcohol induces synaptotagmin 1 expression in neurons via activation of heat shock factor 1. Neuroscience 2011, 193:63-71.
69. Wang L.H., Yang J.Y., Cui W., Shin Y.K., Wu C.F. Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 2008, 128:1067-1071.
70. Mason S., Anthony B., Lai X., Ringham H.N., Wang M., Witzmann F.A., et al. Ethanol exposure alters protein expression in a mouse model of fetal alcohol spectrum disorders. International Journal of Proteomics 2012, 2012:867141.
71. Myung J., Kim K.B., Crews C.M. The ubiquitin-proteasome pathway and proteasome inhibitors. Medicinal Research Reviews 2001, 21:245-273.
72. Bousquet-Dubouch M.P., Nguen S., Bouyssie D., Burlet-Schiltz O., French S.W., Monsarrat B., et al. Chronic ethanol feeding affects proteasome-interacting proteins. Proteomics 2009, 9:3609-3622.
73. Donohue T.M., Kharbanda K.K., Casey C.A., Nanji A.A. Decreased proteasome activity is associated with increased severity of liver pathology and oxidative stress in experimental alcoholic liver disease. Alcoholism, Clinical and Experimental Research 2004, 28:1257-1263.
74. Thomes P.G., Trambly C.S., Thiele G.M., Duryee M.J., Fox H.S., Haorah J., et al. Proteasome activity and autophagosome content in liver are reciprocally regulated by ethanol treatment. Biochemical and Biophysical Research Communications 2012, 417:262-267.
75. Bardag-Gorce F., Li J., French B.A., French S.W. The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal. Experimental and Molecular Pathology 2005, 78:109-115.
76. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine 2008, 29:9-16.